Futures Rebound from February Funk
Stock futures rose Thursday as Nvidia shares advanced following better-than-expected quarterly results.Futures for the Dow Jones Industrials hiked 111 points, or 0.3%, to 43,613Futures for the S&P 500 index retreated 37.75 points, or 0.6%, to 6,008.50.Futures for the tech-heavy NASDAQ sprinted 179.50 points, or 0.9%, to 21,366.30. Nvidia rose 1.8% after the chip giant exceeded fourth-quarter estimates on the top and bottom lines. The company issued strong guidance, reflecting continued demand driven by the artificial intelligence race.Other tech shares also rose on Thursday. Broadcom and Tesla climbed around 2.3%. each.On Wednesday, stocks came off the session’s highs as investors grew concerned about President Donald Trump’s trade policies. At his first cabinet meeting, he said that duties against Canada and Mexico would take effect and that his trade war will include a 25% tariff on goods from the European Union.Traders will have an eye on Thursday’s weekly jobless claims, but they’re looking ahead to Friday’s personal consumption expenditures price index — the Federal Reserve’s preferred inflation gauge.In Japan, the Nikkei 225 added 0.3%, while in Hong Kong, the Hang Seng fell 0.3%. Oil prices grabbed 82 cents to $69.44 U.S. a barrel. Gold prices slid $29.80 to $2,900.80 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


